Royalty Pharma's battle for Elan

Royalty Pharma's bitter battle to take over Elan is in the balance. Elan's shares have soared since the bid was launched, but threaten to fall back if it fails. Lex's Oliver Ralph and Vincent Boland discuss what is at stake in this takeover saga.